Skip to main content
IJID Regions logoLink to IJID Regions
editorial
. 2025 Mar 19;14(Suppl 2):100587. doi: 10.1016/j.ijregi.2025.100587

Inequities underlie the alarming resurgence of Tuberculosis as the world's top cause of death from an Infectious Disease - Breaking the silence and addressing the underlying root causes

Alimuddin Zumla 1, Suvanand Sahu 2, Lucica Ditiu 2, Urvasha Singh 3, Young-Joon Park 4, Dorothy Yeboah-Manu 5, Stephen Osei-Wusu 5, Danny Asogun 6, Peter Nyasulu 7, John Tembo 8, Nathan Kapata 9, Fatma Alyaqoubi 10, Amal Al Maani 10, Lucille Blumberg 11, Adam Zumla 12, Rizwan Ahmed 12, Unyeong Go 13, David S Hui 14, Delia Goletti 15, Eskild Petersen 16,
PMCID: PMC11973691  PMID: 40201557

Highlights

  • The WHO End TB strategy is stalling as shown in the Global Tuberculosis Report 2023.

  • The main reason is unequal access to tuberculosis diagnosis and treatment.

  • Tuberculosis diagnosis and treatment must be expanded outside urban centers down to the smallest and most remote unit.

  • Screening risk populations for latent tuberculosis will help identify infected persons before they develop active tuberculosis.


The World Health Organization (WHO) Global Tuberculosis (TB) Report 2024 [1] brought disappointing news regarding progress towards achieving the United Nations (UN) General Assembly (UNGA) End TB Strategy targets for TB control [2]. As the world is now recovering from disruptions in TB control programs due to the COVID-19 pandemic [3], in 2023, TB returned with a vengeance to being the world's leading cause of death from a single infectious agent and caused almost twice as many deaths as HIV/AIDS”. The Report states “More than 10 million people continue to fall ill with TB every year and the numbers have been rising since 2021” [1]. The world is yet again running out of time to deliver the WHO End TB targets [3,4]. The global response, despite decades of declarations, frameworks, and targets, remains grossly insufficient. Only 26% of the $22 billion required annually for TB care and prevention is available. Research funding fares worse, with merely 20% of the $5 billion annual target achieved [1]. These funding gaps continue to hinder essential progress, including acquisition and rollout of new diagnostics, shorter treatment regimens, and development and evaluation of effective new vaccines.

Moving Beyond the Status Quo

The foundations of the UNGA and WHO End TB roadmaps are based on an equitable approach to TB prevention, care and treatment. These laudable principles are deeply rooted in the recognition of the gross disparities in healthcare access and economic challenges that exist in low- and middle-income countries (LMICs).

Several current approaches to TB control continue to view the global TB crisis as a stagnant challenge and should now be viewed as a dynamic global health crisis with recognition of persisting inequities [[4], [5], [6]]. What the world now needs to seriously recognise is that, despite many rallying cries over three decades for more financial investments required for TB control programs [7,8], TB remains firmly ingrained as a disease of inequality in its many forms [[9], [10], [11], [12], [13], [14]]. The persistence of TB as the world's leading killer infectious disease reflects numerous structural inequities at every level of society [[9], [10], [11], [12], [13], [14]]. These inequities which are rooted in socioeconomic disparities, systemic neglect, and denial of basic rights all create a fertile environment for TB to thrive [[11], [12], [13], [14], [15]]. The key dimensions of these inequities require more focused discussion at governmental and donor levels to add to the never ending but unheeded calls for made for new diagnostics, drugs and vaccines every Word TB Day since it was declared a global emergency in 1992 by the WHO.

Poverty and Tuberculosis

The links between poverty and TB have been locked in a vicious cycle since Victorian times [[8], [9], [10], [11], [12], [13], [14]] and will not be unravelled until there is global peace and security and the UN Charter on human rights is abided by every country in the world. People living in poverty and displaced populations arising from conflict zones and natural disasters, are more likely to experience malnutrition, overcrowded housing, inadequate sanitation, and lack of access to proper health care - all of which increase susceptibility to Mycobacterium tuberculosis infection and development of active TB disease [16]. The economic burden on patients with active TB is related to lost income, high out-of-pocket costs, and prolonged treatment which can entrench them further into the poverty-disease cycle [17,18]. Over 50% of TB-affected households globally face catastrophic healthcare expenditures [1]. In India, where 60% of the population earns less than $2 per day, TB care costs often force families to sell assets or take loans, perpetuating intergenerational poverty [18].

Community Awareness and Education

In sub-Saharan Africa, regions with lower literacy rates report higher TB prevalence, as education directly influences health literacy and access [13], [14], [15]. Lack of education compounds TB risk by limiting awareness of preventive measures and delaying care-seeking behaviour. Low literacy rates correlate with lower adherence to TB treatment regimens, increasing the likelihood of drug resistance and transmission within communities. Education campaigns targeting women and youth have shown measurable reductions in TB incidence by promoting early detection and prevention strategies [15].

Inequities in Healthcare

Healthcare inequities have never been starker in TB care [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], and many high-burden countries, rural populations and marginalized groups lack access to TB diagnostics, trained personnel, and effective treatment. Only 48% of TB patients globally are diagnosed with WHO-recommended rapid molecular tests [1]. Delays in diagnosis prolong infectious periods and worsen outcomes and​ urban-rural divide play important roles. For example, in Indonesia, TB detection rates are 35% higher in urban areas than in rural ones, reflecting disparities in healthcare infrastructure. Gender Disparities in patriarchal societies, women often face barriers to accessing TB care, leading to underreporting and worse health outcomes [1], [18], [19]. TB is often a slowly evolving disease, and diagnostic tests often need to be repeated over time and treatment depends on a regular supply of four drugs over six months with regular follow up to ensure adherence [19].

Intersectionality of inequities are important, and many dimensions of inequity overlap prevail. For instance, women in rural areas not only face healthcare access challenges but also encounter stigma and economic hardship. Thus context-specific approaches such as culturally sensitive outreach, gender-targeted care, and infrastructure development could yield tangible results. There are proven examples from Brazil, South Africa, and the Philippines demonstrate that addressing inequities can have ripple effects, reducing TB incidence while improving overall health outcomes.

Inequities in TB care for Displaced Populations

Other marginalized populations include refugees, prisoners, and migrants and these continue to face systemic barriers to TB care [1,15,20]. These groups often lack identification documents, legal protections, and social safety nets, leading to exclusion from public health programs. Refugees are 10 times more likely to develop TB compared to the general population due to crowded living conditions and limited access to healthcare. In Europe, targeted TB interventions in refugee camps have improved detection rates but remain underfunded and inconsistent 

Impact of Undernutrition and poor Housing on TB Susceptibility

Food insecurity, and undernutrition weakens the immune system, making individuals more susceptible to a range of infectious diseases including TB [12,13]. Conversely, TB exacerbates malnutrition through appetite loss and metabolic demands, creating a feedback loop that worsens outcomes. Over 2.3 million TB cases annually are attributed to malnutrition, making it the largest risk factor for TB globally. Recently, nutritional support programs in Bangladesh and India have significantly reduced TB incidence by improving overall community health [1].

Housing and poor living conditions such as overcrowding and poor ventilation facilitate the airborne transmission of TB. Marginalized communities, including refugees and migrant workers, are particularly at risk due to substandard housing and lack of legal protections. Studies show that improving ventilation in households reduces TB transmission by 40% in high-TB burden areas. South Africa's housing initiatives have reduced TB transmission in mining communities, where living conditions previously contributed to hyperendemic levels [15,17,20].

Can what has been done successfully elsewhere, be replicated for TB?

South Africa has the largest antiretroviral therapy program in the world, and between 2010-2023 has seen HIV incidence fall by 58% [15,21]. South Africa has thus shown the way forward for reducing AIDS-related deaths by 59% since 2000 and reducing AIDS-related deaths since 2010 has decreased by 57%. Seven countries (Botswana, Eswatini, Kenya, Malawi, Rwanda, Zambia and Zimbabwe) have already reached the 95–95–95 testing and treatment targets for the general population [1,[20], [21], [22]]. One key element in interrupting the curve was to decentralize HIV management into small and remote health care facilities and making the number of patients for each facility manageable. This could now be advanced for TB as well ensuring that even remote facilities have the resources, knowledge, diagnostics and treatments available, with sufficient backup for up in the system for managing and referring complicated cases.

Actionable solutions

In addition to the urgent country-level political and financial actions required [23] a ‘New Lens’ with ‘reducing inequities’ at its core is now essential for achieving global TB control. Several articles in this special World TB Day issue of IJID Regions describe proactive screening for latent TB infections with roll out of preventive treatment in psotive cases. However this will require overcoming logistical issues with adequate resources.

Key insights on inequities driving the ongoing TB Epidemic and possible solutions with examples are given in Table 1. This table demonstrates the multifaceted nature of TB inequities and emphasizes actionable solutions with real-world examples to inspire policymakers and healthcare providers.

Table 1.

Inequities Driving the TB Epidemic - key insights and possible solutions.

Dimension Impact on TB Epidemic Statistics Solutions Case Studies/Examples -from Refs [1,17,19]
Poverty Increases exposure to risk factors like malnutrition, poor housing, and delays in care 50% of TB-affected households face catastrophic costs Universal health coverage, poverty alleviation programs Philippines’ Sin Tax Reform: Raised funds through taxation of tobacco and alcohol to support TB care
Education Limits awareness and adherence to TB care Low literacy regions show 20-40% higher TB prevalence Community-led education programs Community Health Workers (CHWs) in Ethiopia trained to improve TB awareness and referrals in rural areas
Healthcare Access Creates barriers to timely diagnosis and treatment Only 48% of patients receive rapid diagnostic tests Strengthen rural health systems, ensure gender-sensitive care Indonesia's TB program increased rural diagnostic access using mobile X-ray units
Food Security Increases susceptibility to infection and worsens outcomes 2.3 million cases annually linked to malnutrition Nutritional support as part of TB treatment Brazil's Bolsa Família program tied financial aid to nutritional improvements, reducing TB incidence
Housing Facilitates airborne transmission 30-50% of urban poor live in overcrowded housing in high-burden areas Policies to improve ventilation and living conditions South Africa's Mining Charter required employers to improve living conditions for workers
Basic Rights Excludes vulnerable populations from TB services a).Refugees are 10x more likely to develop TB Legal protections and targeted TB programs for migrants and refugees a). Europe's cross-border TB detection and care program for migrant populations showed improved case detection
b).Prisoners and incarcerated people have high incidence of all forms of TB. Only 50% of TB cases in prisons are detected. Improving prisons’ TB health services b). Systematic routine and periodical TB screening in a prison in Thailand showed reduced TB prevalence in prisons
Gender Inequity Limits access to care for women in patriarchal societies Women in South Asia experience a 30% diagnostic delay compared to men Gender-sensitive outreach, free or subsidized transport to clinics Afghanistan's home-based TB treatment for women through female health workers increased case detection
Stigma Delays diagnosis and leads to underreporting Stigma linked to TB can reduce care-seeking behaviour by 40% in some regions Community-driven destigmatization campaigns Zambia's TB ‘Champions Program’ empowered survivors to share their stories and reduce stigma in communities
Health System Underfunding Weakens ability to implement widespread diagnostic and treatment programs $5.7 billion funding gap for TB programs in 2023 Sustainable domestic funding, global financing initiatives India's National Strategic Plan for TB aimed to bridge funding gaps through domestic resources
Employment Inequities Forces TB-affected individuals out of the workforce due to stigma and long treatment durations TB patients lose 20-30% of annual income due to the disease Workplace TB policies ensuring non-discrimination, wage protection Vietnam introduced workplace TB policies that supported continued employment during treatment
Geographic Inequities Rural populations face delayed care and lower treatment success Rural TB patients are 50% less likely to complete treatment in Africa Mobile clinics, telemedicine solutions Kenya's programs (eg AMPATH) used community-based TB care to improve rural treatment rates

Conclusions

Tuberculosis has long been recognized as a preventable and treatable illness inextricably linked to poverty, inequality, and systemic neglect. Yet, in 2025, three decades after being declared a ‘Global emergency’ by the WHO [24] TB remains the leading cause of death from an infectious disease globally, with nearly 1.25 million deaths and more than 10.8 million new cases reported. This dismal status quo reflects a persistent disregard for the socioeconomic determinants of health and failure to advance medical interventions.

Whilst some of the data in the 2024 WHO Global TB Report [1] are encouraging, TB incidence rates are rising again after years of decline, particularly in regions with fragile health systems. This World TB Day March 24th, 2025, we call for a radical reframing of the global response so that it addresses TB as a reflection of inequity and a major test of the world's commitment to health justice. Addressing TB requires a more holistic approach that now places 'Equity' at its core. It is not just about medical interventions but tackling the root social and economic causes of poverty, malnutrition, poor living conditions, and systemic health services neglect. Closing these gaps will not only combat TB but also build more resilient and equitable societies. The fight against TB is a fight for justice [[8], [9], [10]]. Justice for the poor, disadvantaged and neglected members of all communities worldwide. Let us ensure this world TB Day March 24th, 2025, that we focus political, civil society, community and funders’ attention on redressing this injustice and that no one is left behind and to governments and donors we say “Yes! We Can End TB: Commit, Invest, Deliver”.

Author Declarations

All authors have an academic interest in Tuberculosis. All authors declare no conflicts of interest.

Acknowledgments

Acknowledgements

Alimuddin Zumla, Dorothy Yeboah-Manu, Dannu Asogun, John Tembo, and Nathan Kapata acknowledge support from the Pan-African Network for Rapid Research, Response, Relief and Preparedness for Emerging and Re-Emerging Infections (PANDORA-ID-NET), funded by the EU-EDCTP2–EU Horizon 2020 Framework Programme. Alimuddin Zumla is in receipt of a UK NIHR Senior Investigator Award and is in receipt of The Mahathir Science Award and EDCTP Pascoal Mocumbi Prize. Delia Goletti is partially supported by the Italian Ministry of Health (Ricerca Corrente, Linea 4). Eskild Petersen, PandemiX Center, Roskilde University is supported by a grant from the Danish National Research Foundation (grant No. DNRF170) and the Carlsberg Foundation (grant number CF20-0046).

Authors’ Contributions

Eskild Petersen and Alimuddin Zumla wrote the first draft. All the authors contributed to developing subsequent drafts and finalising the editorial.

Support disclosure

This article is published as part of a supplement sponsored by QIAGEN Sciences Inc.

Contributor Information

Alimuddin Zumla, Email: a.zumla@ucl.ac.uk.

Suvanand Sahu, Email: sahus@stoptb.org.

Lucica Ditiu, Email: lucicad@stoptb.org.

Urvasha Singh, Email: ddgtb@rntcp.org.

Young-Joon Park, Email: pahmun@korea.kr.

Dorothy Yeboah-Manu, Email: DYeboah-Manu@noguchi.ug.edu.gh.

Stephen Osei-Wusu, Email: stephenbg128@gmail.com.

Danny Asogun, Email: asogun2001@yahoo.com.

Peter Nyasulu, Email: pnyasulu@sun.ac.za.

John Tembo, Email: John.Tembo@gmail.com.

Nathan Kapata, Email: Nkapata@gmail.com.

Fatma Alyaqoubi, Email: fatmayaquobi@gmail.com.

Amal Al Maani, Email: amalsaifalmaani@gmail.com.

Lucille Blumberg, Email: lucilleb@nicd.ac.za.

Adam Zumla, Email: zumla@hotmail.co.uk.

Rizwan Ahmed, Email: rizwanyahya@hotmail.com.

Unyeong Go, Email: unyng@naver.com.

David S Hui, Email: dschui@cuhk.edu.hk.

Delia Goletti, Email: delia.goletti@inmi.it.

Eskild Petersen, Email: eskild.petersen@gmail.com.

References

  • 1.WHO. Global Tuberculosis Report. 2024. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024. (Accessed 5th January, 2024).
  • 2.WHO End TB strategy. https://www.who.int/teams/global-tuberculosis-programme/the-end-tb-strategy. (Accessed 28th December, 2024).
  • 3.Zumla A, Chakaya J, Khan M, Fatima R, Wejse C, Al-Abri S, et al. World Tuberculosis Day 2021 Theme - 'The Clock is Ticking' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic. Int J Infect Dis. 2021;113(Suppl 1):S1–S6. doi: 10.1016/j.ijid.2021.03.046. Epub 2021 Mar 18. PMID: 33746094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gulumbe BH, Abdulrahim A, Danlami MB. The United Nations' ambitious roadmap against tuberculosis: opportunities, challenges and the imperative of equity. Future Sci OA;10:2418787. doi: 10.1080/20565623.2024.2418787. [DOI] [PMC free article] [PubMed]
  • 5.Wingfield T, Tovar MA, Datta S, Saunders MJ, Evans CA. Addressing social determinants to end tuberculosis. Lancet. 2018;391:1129–1132. doi: 10.1016/S0140-6736(18)30484-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jarde A, Romano E, Afaq S, Elsony A, Lin Y, Huque R, et al. Prevalence and risks of tuberculosis multimorbidity in low-income and middle-income countries: a meta-review. BMJ Open. 2022;12 doi: 10.1136/bmjopen-2022-060906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Marais BJ, Raviglione MC, Donald PR, Harries AD, Kritski AL, Graham SM, et al. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet. 2010;375:2179–2191. doi: 10.1016/S0140-6736(10)60554-5. [DOI] [PubMed] [Google Scholar]
  • 8.Grange J, Mwaba P, Dheda K, Höelscher M, Zumla A. World TB Day 2010–new innovations are required for enhancing the global fight against tuberculosis: the 'captain of all these men of death'. Trop Med Int Health. 2010;15:274–276. doi: 10.1111/j.1365-3156.2009.02462.x. [DOI] [PubMed] [Google Scholar]
  • 9.Zumla A, Grange JM. Is the eradication of tuberculosis 'yesterday's ambition' or 'tomorrow's triumph'? Clin Med (Lond) 2010;10:450–453. doi: 10.7861/clinmedicine.10-5-450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Grange JM, Zumla A. Paradox of the global emergency of tuberculosis. Lancet. 1999;353:996. doi: 10.1016/S0140-6736(99)01196-4. [DOI] [PubMed] [Google Scholar]
  • 11.Grange JM, Zumla A. The global emergency of tuberculosis: what is the cause? J R Soc Promot Health. 2002;122:78–81. doi: 10.1177/146642400212200206. [DOI] [PubMed] [Google Scholar]
  • 12.Grange J, Zumla A. Tuberculosis and the poverty-disease cycle. J R Soc Med. 1999;92:105–107. doi: 10.1177/014107689909200301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bhargava A, Bhargava M, Pai M. Tuberculosis: a biosocial problem that requires biosocial solutions. Lancet. 2024;403:2467–2469. doi: 10.1016/S0140-6736(24)00489-6. [DOI] [PubMed] [Google Scholar]
  • 14.WHO: State of inequality: HIV, tuberculosis and malaria: 2021 https://www.who.int/publications/i/item/9789240039445. (Accessed December 25th, 2024).
  • 15.van der Westhuizen HM, Giddy J, Coetzee R, Makanda G, Tisile P, Galloway M, et al. Strengthening accountability for tuberculosis policy implementation in South Africa: perspectives from policymakers, civil society, and communities. BMC Glob Public Health. 2024;2:48. doi: 10.1186/s44263-024-00077-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Reid M, Agbassi YJP, Arinaminpathy N, Bercasio A, Bhargava A, Bhargava M, et al. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. Lancet. 2023 Oct 21;402(10411):1473–1498. doi: 10.1016/S0140-6736(23)01379-X. Epub 2023 Sep 13. PMID: 37716363. [DOI] [PubMed] [Google Scholar]
  • 17.WHO Report: 2024. International donor funding for tuberculosis: an analysis of donor reports to the organisation for economic co-operation and development. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024/tb-financing/4-2-international-donor-funding-for-tuberculosis. (Accessed January 15th 2024).
  • 18.Chatterjee S, Das P, Stallworthy G, Bhambure G, Munje R, Vassall A. Catastrophic costs for tuberculosis patients in India: Impact of methodological choices. PLOS Glob Public Health. 2024;4 doi: 10.1371/journal.pgph.0003078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.The Global Fund. Tuberculosis. https://www.theglobalfund.org/en/tuberculosis/. (Accessed January 10th 2025).
  • 20.Castro KG, Ditiu L, Sahu S, Ntoumi F, Tiberi S, O'Kane CM, et al. Optimising tuberculosis care for refugees affected by armed conflicts. Lancet Respir Med. 2022;10:533–536. doi: 10.1016/S2213-2600(22)00104-7. [DOI] [PubMed] [Google Scholar]
  • 21.UNAIDS . Joint United Nations Programme on HIV/AIDS; Geneva: 2024. The urgency of now: AIDS at a crossroads. [Google Scholar]; https://www.unaids.org/en/resources/documents/2024/global-aids-update-2024. (Accessed 30th December 2024).
  • 22.Global Fund. Results Report 2024. core_2024-results_report_en.pdf. (Accessed 30 December, 2024).
  • 23.Sahu S, Ditiu L, Ahmed R, Zumla A, Aklillu E, Singh UB, Yeboah-Manu D, Asogun D, Hui DS, Zumla A. Overcoming the global tuberculosis crisis with urgent country-level political and financial action. Lancet Infect Dis. Jan 2025;25(1):14–16. doi: 10.1016/S1473-3099(24)00748-5. Epub 2024 Nov 19. PMID: 39577455. [DOI] [PubMed] [Google Scholar]
  • 24.WHO – a Global Emergency. Geneva. World Health Organization. 1994 (WHO/TB/94.177). https://iris.who.int/handle/10665/58749. (Accessed 19th January, 2025).

Articles from IJID Regions are provided here courtesy of Elsevier

RESOURCES